These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7614221)

  • 1. Certain legal aspects of derivatives.
    Cloney TJ
    J Health Care Finance; 1994; 21(2):22-34. PubMed ID: 7614221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of interest rate swaps by nonprofit organizations: evidence from nonprofit health care providers.
    Stewart LJ; Trussel J
    J Health Care Finance; 2006; 33(2):6-22. PubMed ID: 19175237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coming changes in tax-exempt health care finance.
    Carlile LL; Serchuk BM
    J Health Care Finance; 1995; 22(1):1-42. PubMed ID: 8528823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bonds under scrutiny. IRS audit to look at how the proceeds are used.
    Taylor M
    Mod Healthc; 2005 Jul; 35(30):12. PubMed ID: 16101249
    [No Abstract]   [Full Text] [Related]  

  • 5. Filling the information gap. Not-for-profits are gradually opening up to bondholders.
    Carpenter D
    Trustee; 2001 Jun; 54(6):29-33. PubMed ID: 11417005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SFAS No. 124, accounting for investments: the rules have changed.
    Luecke RW; Meeting DT; Giniat EJ
    Healthc Financ Manage; 1996 Dec; 50(12):58-63. PubMed ID: 10163007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interest rate derivative transactions on debt savings for not-for-profit health systems.
    Venkataramani P; Johnson T; O'Neil P; Poindexter V; Rooney J
    J Health Care Finance; 2006; 33(2):23-38. PubMed ID: 19175238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Funding working capital with tax-exempt debt.
    Schieble MT
    Health Care Law Newsl; 1992 Nov; 7(11):3-7. PubMed ID: 10122687
    [No Abstract]   [Full Text] [Related]  

  • 9. IRS issues new disclosure rules for tax-exempt organizations.
    Luecke RW; Shortill KJ
    Healthc Financ Manage; 1999 Dec; 53(12):52-4. PubMed ID: 11066696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financing medical office buildings.
    Blake JW
    J Health Care Finance; 1995; 22(1):43-8. PubMed ID: 8528824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed changes in arbitrage rules aim to simplify cumbersome process.
    Nemes J
    Mod Healthc; 1992 Nov; 22(47):54. PubMed ID: 10122243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRS is making it easier for hospitals to borrow tax-exempt working capital.
    Nemes J
    Mod Healthc; 1992 Jul; 22(29):34-5. PubMed ID: 10119416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward full disclosure. As healthcare bond issuers face more troubles, pressure mounts for more information sharing with investors.
    Jaklevic MC
    Mod Healthc; 2001 Feb; 31(8):50-2, 54. PubMed ID: 11234175
    [No Abstract]   [Full Text] [Related]  

  • 14. Want capital? Try a new approach.
    Hessler F
    Health Forum J; 2000; 43(3):suppl 10-1. PubMed ID: 11010146
    [No Abstract]   [Full Text] [Related]  

  • 15. Three approaches to better disclosure.
    Carpenter D
    Health Forum J; 2001; 44(3):suppl 12-8. PubMed ID: 11372274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Nonprofits' need surplus too.
    Young DW
    Harv Bus Rev; 1982; 60(1):124-31. PubMed ID: 10253782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better investor relations. A financier outlines some ways health care organizations can improve their access to capital.
    Hessler F
    Health Forum J; 2001; 44(3):suppl 10-1. PubMed ID: 11372273
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking the provider-driven company public: a primer on business and legal issues.
    Becker S; Pristave RJ; Liebers EH
    J Health Care Finance; 1996; 22(4):71-80. PubMed ID: 8827487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical company sponsored disease management programs: an alternative for tax-exempt MCOs and hospitals.
    Jedrey CM; Chaurette KA; Winn LB
    Manag Care Q; 2002; 10(3):11-5. PubMed ID: 12476660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tax-exempt bonds scrutinized. CBO studies use by hospitals, other not-for-profit.
    Taylor M
    Mod Healthc; 2006 Feb; 36(6):4. PubMed ID: 16515077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.